Cidel Asset Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-326,349
Closed -$21.2M 86
2017
Q2
$21.2M Buy
326,349
+4,913
+2% +$310K 0.98% 30
2017
Q1
$20.3M Buy
321,436
+15,423
+5% +$928K 0.98% 30
2016
Q4
$17.7M Buy
306,013
+27,219
+10% +$1.61M 0.88% 32
2016
Q3
$16.6M Buy
278,794
+23,864
+9% +$1.47M 0.91% 32
2016
Q2
$15.8M Buy
254,930
+10,849
+4% +$668K 0.92% 29
2016
Q1
$15M Buy
+244,081
New +$14.4M 0.9% 29

Other funds holding XRAY

Cidel Asset Management's XRAY Position: Q3 2017 in Review

Cidel Asset Management sold out of Dentsply Sirona (XRAY) in Q3 2017, closing a stake of 326,349 shares — an estimated $21.2M sold.

Cidel Asset Management first reported a position in XRAY in Q1 2016 and held it in 6 quarters. The position peaked at $21.2M in Q2 2017. 536 funds tracked by Wall St. Rank hold XRAY as of Q3 2017.

  • Cidel Asset Management reported no remaining Dentsply Sirona position as of Q3 2017 after selling out during the quarter.
  • Cidel Asset Management sold 326,349 Dentsply Sirona shares in Q3 2017, an estimated $21.2M.
  • Cidel Asset Management first reported a position in Dentsply Sirona in Q1 2016 and held it in 6 quarters.
  • Cidel Asset Management's Dentsply Sirona position peaked at $21.2M in Q2 2017.
  • 536 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2017.

Based on Cidel Asset Management's 13F filing for Q3 2017, filed 31 Oct 2017.